"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
click to copy
Mitomycin C cell division inhibitor, nucleic acid inhibitor, and phage inducer; Clinically used as anti-tumor drugs. This product has a wide anti-tumor spectrum, and has good effect for gastric cancer and breast cancer. It is effective for lung cancer, liver cancer, malignant lymphoma, Hodgkin's disease, reticular cell sarcoma, uterine cancer, leukemia, intestinal cancer and pancreatic cancer, but the remission period is short. The combination with urokinase can improve the therapeutic effect. This product has a rapid effect, but the number of treatment operators is not high and the toxicity is high. Both bleomycin and its derivatives, such as bleomycin, are antibiotics and anticancer drugs that damage DNA, causing cell DNA to disintegrate and inhibiting DNA replication in proliferating cells. The LD50 for intravenous injection in mice is 5ml/kg. Anticancer drugs are commonly used to treat digestive system cancers.
Product Name | Item number | Specifications |
Mitomycin C (Mitomycin C) | AB11L162 | 50 mg |
Transport at room temperature. Stored at 4 ℃, with a shelf life of 24 months.
This product is only for scientific experimental research and should not be used in clinical diagnosis, treatment, or other fields.
Fill in the product batch number for querying
Fill in the product batch number for querying
Hot-sale Product
Hot Articles